Printable: Options for myeloma patients who have undergone Darzalex (daratumumab) therapy and relapsed

Options for myeloma patients who have undergone Darzalex (daratumumab) therapy and relapsed (https://www.myeloma.org/videos/options-myeloma-patients-who-have-undergone-darzalex-daratumumab-therapy-relapsed)

In this week’s video, Dr. Brian G.M. Durie explains that if you relapse on Darzalex, it is important to carefully discuss all treatment options with your doctor.

BOTTOM LINE:
If you relapse while on Darzalex, consider all options including upping dosing, new combination therapies, second transplant, or even a clinical trial.

Author

Dr. Brian GM Durie (https://www.myeloma.org/Brian-Durie-md)

Video

Series

Ask Dr. Durie (https://www.myeloma.org/taxonomy/term/19)

Old Id

1518

Ask a Question

Please note that Ask Dr. Durie has been discontinued, and it was designed to address myeloma questions of the broadest possible audience interest. If you have a question of a personal nature, please contact our InfoLine Coordinators at 800.452.2873 or [email protected] (mailto:[email protected]) (Please do not send email attachments or lab reports.).

Image of Dr. Brian G.M. Durie Dr. Brian G.M. Durie (1942-2025) was the co-founder of the IMF. He was a Professor of Medicine, Hematologist/Oncologist, and Honoree MD at the University of Brussels.